🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Diabetic nephropathy (DN) is one of the most frequent microvascular complic...
Status
Completed
Location
Nancy Elbarbary
Start Date
2022-03-01
Trial ID
NCT06115460
Treatments Being Tested
Over the years, numbers of cardioprotective drugs have been evaluated to at...
Status
Unknown
Location
Kyung Hee University Hospital
Start Date
2015-02
Trial ID
NCT02406950
Treatments Being Tested
Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagl...
Status
Not Yet Recruiting
Location
Northwell Health
Start Date
2026-07-01
Trial ID
NCT07675174
Treatments Being Tested
The study is a multicenter, prospective, open-label, randomized pilot study...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2011-08
Trial ID
NCT01378117
Treatments Being Tested
The main purpose of this study is to compare the pharmacokinetics (how the ...
Status
Completed
Location
The Affiliated Hospital of Qingdao University
Start Date
2023-02-14
Trial ID
NCT07679711
The present study is a phase I, single-centre, double-blind, randomized, cr...
Status
Completed
Location
Diabeteszentrum Bad Lauterberg
Start Date
2011-11
Trial ID
NCT02749032
Treatments Being Tested
Glucose Variability With DPP-4 Inhibition...
Status
Unknown
Location
Multiple Locations
Start Date
2013-05
Trial ID
NCT01751321
Treatments Being Tested
Our trial goal is to determine the efficacy and safety of sitagliptin in co...
Status
Completed
Location
University of Sadat City
Start Date
2020-09-20
Trial ID
NCT05359341
Patients with pre-transplantation type 2 diabetes (T2D) and new-onset diabe...
Status
Completed
Location
Division Of Endocrinology & Diabetes, Medanta The Medicity
Start Date
2022-01-01
Trial ID
NCT05042505
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1245.10.10026 Boehringer Ingelheim Investigational Site
Start Date
2008-08
Trial ID
NCT00749190
Treatments Being Tested